{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:24:26Z","timestamp":1793852666620,"version":"4.6.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2024.117208","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:45:33Z","timestamp":1735317933000},"page":"117208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis and functional screening of novel inhibitors targeting the HDAC6 zinc finger ubiquitin-binding domain"],"prefix":"10.1016","volume":"285","author":[{"given":"Silke","family":"Geurs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Staessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kato","family":"Bredael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"Borghgraef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordy","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Persoons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep K.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorick","family":"Franceus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien","family":"Clarisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolien","family":"De Bosscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-4337","authenticated-orcid":false,"given":"Matthias","family":"D'hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6887","key":"10.1016\/j.ejmech.2024.117208_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117208_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/msb.2013.26","article-title":"The functional interactome landscape of the human histone deacetylase family","volume":"9","author":"Joshi","year":"2013","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Sim\u00f5es-Pires","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117208_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1042\/CS20160084","article-title":"The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease","volume":"130","author":"Batchu","year":"2016","journal-title":"Clinical Science"},{"key":"10.1016\/j.ejmech.2024.117208_bib5","volume":"vol. 2011","author":"Aldana Masangkay","year":"2011"},{"key":"10.1016\/j.ejmech.2024.117208_bib6","article-title":"HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease","volume":"5","author":"Benoy","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cc.7.1.5186","article-title":"HDAC6 a new cellular stress surveillance factor","volume":"7","author":"Matthias","year":"2008","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.ejmech.2024.117208_bib9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.ejmech.2024.117208_bib10","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1128\/MCB.21.23.8035-8044.2001","article-title":"Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways","volume":"21","author":"Seigneurin-Berny","year":"2001","journal-title":"Mol. Cell Biol."},{"issue":"21","key":"10.1016\/j.ejmech.2024.117208_bib11","doi-asserted-by":"crossref","first-page":"13425","DOI":"10.1073\/pnas.172511699","article-title":"Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes","volume":"99","author":"Hook","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.ejmech.2024.117208_bib13","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.emboj.7601210","article-title":"HDAC6-p97\/VCP controlled polyubiquitin chain turnover","volume":"25","author":"Boyault","year":"2006","journal-title":"Embo J"},{"issue":"9","key":"10.1016\/j.ejmech.2024.117208_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib15","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1021\/acs.jmedchem.8b00258","article-title":"Identification and structure-activity relationship of HDAC6 zinc-finger ubiquitin binding domain inhibitors","volume":"61","author":"Ferreira de Freitas","year":"2018","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2024.117208_bib16","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1021\/acs.jmedchem.7b00933","article-title":"Small molecule antagonists of the interaction between the histone deacetylase 6 zinc-finger domain and ubiquitin","volume":"60","author":"Harding","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117208_bib17","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination","volume":"26","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.ejmech.2024.117208_bib18","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev."},{"issue":"48","key":"10.1016\/j.ejmech.2024.117208_bib19","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.M508786200","article-title":"HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin","volume":"280","author":"Iwata","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117208_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"issue":"7146","key":"10.1016\/j.ejmech.2024.117208_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejmech.2024.117208_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5865","key":"10.1016\/j.ejmech.2024.117208_bib23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib24","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1074\/jbc.M111.273730","article-title":"Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini","volume":"287","author":"Ouyang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2013.08.016","article-title":"Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains","volume":"51","author":"Hao","year":"2013","journal-title":"Mol. Cell"},{"issue":"6968","key":"10.1016\/j.ejmech.2024.117208_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejmech.2024.117208_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/1947601910383277","article-title":"The role of ubiquitin in autophagy-dependent protein aggregate processing","volume":"1","author":"Yao","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ejmech.2024.117208_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2013.12.015","article-title":"Proteotoxicity: an underappreciated pathology in cardiac disease","volume":"71","author":"Sandri","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0092-8674(91)90611-2","article-title":"Heat shock, stress proteins, chaperones, and proteotoxicity","volume":"66","author":"Hightower","year":"1991","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ejmech.2024.117208_bib30","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin\u2013proteasome pathway: on protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","article-title":"The ubiquitin-proteasome proteolytic pathway","volume":"79","author":"Ciechanover","year":"1994","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib32","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","article-title":"United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy","volume":"12","author":"Kane","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib33","article-title":"Bortezomib for the treatment of multiple myeloma","author":"Scott","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2024.117208_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biocel.2014.03.015","article-title":"Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome","volume":"51","author":"Bonanomi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"34","key":"10.1016\/j.ejmech.2024.117208_bib35","doi-asserted-by":"crossref","first-page":"28576","DOI":"10.1074\/jbc.M111.299990","article-title":"Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.ejmech.2024.117208_bib36","doi-asserted-by":"crossref","first-page":"26436","DOI":"10.1074\/jbc.M803692200","article-title":"The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains","volume":"283","author":"Winborn","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1097-2765(03)00498-2","article-title":"The missing linker: an unexpected role for a histone deacetylase","volume":"12","author":"Kopito","year":"2003","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2024.117208_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1034\/j.1600-0854.2002.30602.x","article-title":"Hassles with taking out the garbage: aggravating aggresomes","volume":"3","author":"Garcia-Mata","year":"2002","journal-title":"Traffic"},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110736","article-title":"Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.117208_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114438","article-title":"New insights into the non-enzymatic function of HDAC6","volume":"161","author":"Zhu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.117208_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111842","article-title":"Oxindole and its derivatives: a review on recent progress in biological activities","volume":"141","author":"Khetmalis","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.117208_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2164558","article-title":"Carboxylic acid bioisosteres in medicinal chemistry: synthesis and properties","volume":"2022","author":"Bredael","year":"2022","journal-title":"J. Chem."},{"issue":"42","key":"10.1016\/j.ejmech.2024.117208_bib44","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1039\/D2CC01550A","article-title":"Identification of mercaptoacetamide-based HDAC6 inhibitors via a lean inhibitor strategy: screening, synthesis, and biological evaluation","volume":"58","author":"Geurs","year":"2022","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2024.117208_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.32169","article-title":"Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but no functional tolerance in cancer models","volume":"145","author":"Depetter","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1039\/C8MD00107C","article-title":"Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition","volume":"9","author":"Depetter","year":"2018","journal-title":"MedChemComm"},{"issue":"36","key":"10.1016\/j.ejmech.2024.117208_bib47","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1039\/c3cc41422a","article-title":"Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A","volume":"49","author":"De Vreese","year":"2013","journal-title":"Chem. Commun."},{"issue":"6141","key":"10.1016\/j.ejmech.2024.117208_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.ejmech.2024.117208_bib49","article-title":"Discovery and characterization of a chemical probe targeting the zinc-finger ubiquitin-binding domain of HDAC6","volume":"2023","author":"Harding","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2024.117208_bib50","unstructured":"Consortium, T. S. G. https:\/\/www.thesgc.org\/chemical-probes\/SGC-UBD253."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.ejmech.2024.117208_bib52","article-title":"Structure-activity relationship of 2,4-D correlates auxin activity with the induction of somatic embryogenesis in <em>Arabidopsis thaliana<\/em&gt","volume":"2022","author":"Karami","year":"2022","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040525","article-title":"Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target?","volume":"17","author":"Ram\u00edrez","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib54","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/TP.0000000000005042","article-title":"Differential effects of HDAC6 inhibition versus knockout during hepatic ischemia\u2013reperfusion injury highlight importance of HDAC6 C-terminal zinc-finger ubiquitin-binding domain","volume":"108","author":"Concors","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib55","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/2767-9764.CRC-23-0528","article-title":"HDAC6 inhibition releases HR23B to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activity","volume":"4","author":"Rana","year":"2024","journal-title":"Cancer Research Communications"},{"issue":"14","key":"10.1016\/j.ejmech.2024.117208_bib56","article-title":"Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell proliferation","volume":"2024","author":"Rinc\u00f3n","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.ejmech.2024.117208_bib57","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.ejmech.2024.117208_bib58","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.202445099","article-title":"Molecular sequelae of proteasome inhibition in human multiple myeloma cells","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib59","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2002-06-1768","article-title":"The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib60","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","article-title":"Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341","volume":"101","author":"Hideshima","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejmech.2024.117208_bib61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14656566.2017.1340942","article-title":"Current and developing synthetic pharmacotherapy for treating relapsed\/refractory multiple myeloma","volume":"18","author":"Podar","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ph10020040","article-title":"Novel proteasome inhibitors and histone deacetylase inhibitors: progress in myeloma therapeutics","volume":"10","author":"Chhabra","year":"2017","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ejmech.2024.117208_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.beha.2007.09.008","article-title":"From the bench to the bedside: emerging new treatments in multiple myeloma","volume":"20","author":"Mitsiades","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117208_bib64","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1158\/1078-0432.CCR-07-2218","article-title":"Proteasome inhibitors in cancer therapy: lessons from the first decade","volume":"14","author":"Orlowski","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","article-title":"Proteasome inhibitors: an expanding army attacking a unique target","volume":"19","author":"Kisselev","year":"2012","journal-title":"Chem. Biol."},{"issue":"7182","key":"10.1016\/j.ejmech.2024.117208_bib66","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2353\/ajpath.2007.070188","article-title":"Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability","volume":"171","author":"Ding","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.ejmech.2024.117208_bib68","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-16-2526","article-title":"Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma","volume":"23","author":"Vogl","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6059","key":"10.1016\/j.ejmech.2024.117208_bib69","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.117208_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1083\/jcb.201210077","article-title":"Development of proteasome inhibitors as research tools and cancer drugs","volume":"199","author":"Goldberg","year":"2012","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40268-019-0269-9","article-title":"Bortezomib for the treatment of hematologic malignancies: 15 Years later","volume":"19","author":"Robak","year":"2019","journal-title":"Drugs R"},{"issue":"11","key":"10.1016\/j.ejmech.2024.117208_bib73","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","article-title":"Proteasome inhibitors: valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.117208_bib75","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/oxfordjournals.jbchem.a021280","article-title":"Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine","volume":"119","author":"Tsubuki","year":"1996","journal-title":"J. Biochem."},{"issue":"23","key":"10.1016\/j.ejmech.2024.117208_bib76","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1111\/bph.15653","article-title":"Targeting lipid metabolism in multiple myeloma cells: rational development of a synergistic strategy with proteasome inhibitors","volume":"178","author":"Xu","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.ejmech.2024.117208_bib77","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1182\/blood-2010-03-272393","article-title":"Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes","volume":"116","author":"David","year":"2010","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.ejmech.2024.117208_bib78","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1073\/pnas.0503221102","article-title":"Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma","volume":"102","author":"Hideshima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117208_bib93","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"6208","key":"10.1016\/j.ejmech.2024.117208_bib79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1257037","article-title":"Influenza A virus uses the aggresome processing machinery for host cell entry","volume":"346","author":"Banerjee","year":"2014","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/v8100293","article-title":"Ubiquitin in influenza virus entry and innate immunity","volume":"8","author":"Rudnicka","year":"2016","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ejmech.2024.117208_bib81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"issue":"37","key":"10.1016\/j.ejmech.2024.117208_bib82","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1016\/S0040-4020(00)00595-0","article-title":"Synthesis and reactions of some 2-vinyl-3H-quinazolin-4-ones","volume":"56","author":"Witt","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.117208_bib83","series-title":"CrysAlisPro Software System","year":"2019"},{"key":"10.1016\/j.ejmech.2024.117208_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","volume":"A71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., Sect. A"},{"key":"10.1016\/j.ejmech.2024.117208_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","volume":"C71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., Sect. A"},{"key":"10.1016\/j.ejmech.2024.117208_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107088","article-title":"Acute cell stress screen with supervised machine learning predicts cytotoxicity of excipients","volume":"111","author":"Bieberich","year":"2021","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"20","key":"10.1016\/j.ejmech.2024.117208_bib87","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","article-title":"YASARA view-molecular graphics for all devices-from smartphones to workstations","volume":"30","author":"Krieger","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117208_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0263-7855(90)80070-V","article-title":"What if: a molecular modeling and drug design program","volume":"8","author":"Vriend","year":"1990","journal-title":"J. Mol. Graph."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117208_bib89","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117208_bib90","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117208_bib91","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.117208_bib92","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:07:11Z","timestamp":1740384431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":93,"alternative-id":["S0223523424010900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117208","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and functional screening of novel inhibitors targeting the HDAC6 zinc finger ubiquitin-binding domain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117208"}}